Abstract
Introduction: The outcomes and treatment costs of a cohort of 355 patients (pts) with COPD were evaluated. Methods: Pts with moderate to severe (predicted FEV,
| Original language | English (US) |
|---|---|
| Pages (from-to) | 36S |
| Journal | Chest |
| Volume | 110 |
| Issue number | 4 SUPPL. |
| State | Published - Oct 1 1996 |
All Science Journal Classification (ASJC) codes
- Pulmonary and Respiratory Medicine
- Critical Care and Intensive Care Medicine
- Cardiology and Cardiovascular Medicine
Fingerprint Dive into the research topics of 'Pharmacoeconomic evaluation of COPD: Stratification of outcomes and costs according to initial drug therapy'. Together they form a unique fingerprint.
Cite this
Hilleman, D. E., Wadibia, E. C., & Shinn, B. (1996). Pharmacoeconomic evaluation of COPD: Stratification of outcomes and costs according to initial drug therapy. Chest, 110(4 SUPPL.), 36S.